ALEMBICLTD(ALEMBICLTD)
ALEMBICLTD
$106.29—
BSE
$106.29—
Alembic Ltd. is a prominent entity in the pharmaceutical industry, distinguished for its extensive history and contribution to healthcare solutions. Primarily engaged in the production and development of pharmaceutical products, the company focuses on active pharmaceutical ingredients (APIs) and formulations that cater to a diverse array of medical needs. With a foundation laid in 1907, Alembic Ltd. has evolved into a key player in both domestic and international markets, making significant strides in research and development. Its portfolio covers a range of therapeutic categories, including anti-infective, anti-inflammatory, analgesics, and cardiovascular drugs. Alembic Ltd.'s efforts in innovation and quality assurance underpin its market significance, facilitating the delivery of high-standard health products globally. The company's operations not only impact pharmaceutical supply chains but also play a crucial role in advancing medicinal sciences and healthcare accessibility. Headquartered in Vadodara, India, Alembic Ltd. stands as a testament to enduring legacy and continuous growth within an ever-advancing industry.